[Prolonged preventive treatment of hereditary angioneurotic edema with anabolic androgenic steroids].
Since 1977, 22 patients with hereditary angioneurotic oedema have been treated with androgenic-anabolic steroids (danazol or stanozolol). The most frequent adverse reactions were myalgia, weight increase, changes in libido, and menstrual disorders in women. In view of these side-effects, it is suggested that patients about to undergo surgery (chiefly E.N.T. or stomatology) should be put, one week before the operation, on a 10-day high dosage treatment. Long-term treatment should be reserved to severe forms of the disease, with frequent attacks and visceral involvement, using the minimum effective dosage (which is always low) without trying to correct biochemical abnormalities. Stanozolol should be given by preference to men and danazol to women. Treatment is always more difficult in pre-menopausal women. With this method, the complications, notably hepatic disorders, are rare, and long-term treatment, when absolutely necessary, is well tolerated.
D000293:Adolescent; D000328:Adult; D000368:Aged; D045930:Anabolic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000799:Angioedema / Q000188:drug therapy* / Q000235:genetics / Q000517:prevention & control; D003613:Danazol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008696:Methandrostenolone / Q000008:administration & dosage; D008875:Middle Aged; D013197:Stanozolol / Q000008:administration & dosage; D013997:Time Factors
D045930:Anabolic Agents; D013197:Stanozolol; D008696:Methandrostenolone; D003613:Danazol
Traitement prophylactique prolongé de l'oedème angioneurotique héréditaire par les stéroïdes androgènes anabolisants.